May 20, 2009 – Definiens, an image software company, and Moffitt Cancer Center will utilize Definiens technology in the analysis of lung cancer CT images for the purpose of developing more accurate prognosis and prediction models for response to specific lung cancer therapies.
Image features extracted with Definiens technology will be compared to disease outcomes, as well as gene expression data available through Total Cancer Care, Moffitt’s comprehensive approach to cancer that enables researchers and caregivers to identify and meet all the needs of a patient and their family during the patient’s lifetime and for future generations.
Moffitt is part of an elite group of National Cancer Institute (NCI) Comprehensive Cancer Centers focusing on the development of early stage translational research models. The Center will employ a lung tumor analysis research application developed by Definiens to rapidly and accurately identify, segment and analyze lung tumors from CT and PET/CT fused images. The application will also allow the researchers to measure lung nodule volume, surface-to-volume, attenuation gradient at the edges, shape features, texture and homogeneity measures, as well as tracking tumors’ volumetric changes over time.

“At Moffitt, we are enthusiastic about deploying these cutting-edge tools to support our researchers with their critical work,” said Robert J. Gillies, Ph.D., vice-chair Radiology and director of the Experimental Imaging Program at Moffitt. “We anticipate that the Definiens platform will streamline the analysis of hundreds, if not thousands, of CT and PET images. These numbers are necessary in order to develop more robust patient stratification models.”

Following the release of the pioneering Definiens LymphExpert application for the analysis of lymph nodes, Definiens is developing image analysis applications for a variety of cancer types, addressing lung and liver tumors as next steps. All Definiens medical imaging applications are built upon the company’s proprietary Definiens Cognition Network Technology®, an image analysis technology that examines objects in relation to one another and emulates human cognitive processes to extract intelligence from images.

“We are excited to support Moffitt’s groundbreaking research into cancer therapies and personalized cancer care,” said Frank-P. Klein, Vice President, Medical Imaging at Definiens. “This project provides further confirmation that Definiens’ unique technology can address the most challenging image analysis tasks facing researchers for a variety of cancer types.”

As part of the research engagement, Moffitt scientists will also explore Definiens TissueMap and Definiens Developer for tissue-based image analysis.

For more information: www.moffitt.org and www.definiens.com


Related Content

News | PET-CT

June 19, 2025 — Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research ...

Time June 19, 2025
arrow
News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | SPECT Imaging

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...

Time February 05, 2025
arrow
News | Computed Tomography (CT)

Dec. 3, 2024 — During RSNA '24, GE HealthCare announced the 510(k) submission to the U.S. Food and Drug Administration ...

Time December 18, 2024
arrow
News | SPECT Imaging

Dec. 2, 2024 — GE HealthCare has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing ...

Time December 05, 2024
arrow
News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
Subscribe Now